These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34999659)

  • 1. Determinants of Immune Response to Anti-SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Study.
    Magicova M; Zahradka I; Fialova M; Neskudla T; Gurka J; Modos I; Hojny M; Raska P; Smejkal P; Striz I; Viklicky O
    Transplantation; 2022 Apr; 106(4):842-852. PubMed ID: 34999659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.
    Gulmez R; Ozbey D; Agbas A; Aksu B; Yildiz N; Uckardes D; Saygili S; Yilmaz EK; Yildirim ZY; Tasdemir M; Kiykim A; Cokugras H; Canpolat N; Nayir A; Kocazeybek B; Caliskan S
    Pediatr Nephrol; 2023 Jul; 38(7):2199-2208. PubMed ID: 36459243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to non-mRNA SARS-CoV-2 vaccine in kidney transplant recipients.
    Bajpai D; Bose S; Saxena N; Kulkarni B; Kumar K; Rao N; Thakare S; Torane V; Nataraj G; Jamale T
    Vaccine; 2024 Nov; 42(25):126206. PubMed ID: 39122634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated With Vaccine-Induced T-Cell Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Kidney Transplant Recipients.
    Tometten I; Landmann S; Kantauskaite M; Lamberti J; Hillebrandt J; Müller L; Kittel M; Kolb T; Ivens K; Schmitz M; Voges A; Adams O; Andrée M; Schaal H; Lübke N; Königshausen E; Rump LC; Stegbauer J; Timm J
    J Infect Dis; 2023 Mar; 227(5):641-650. PubMed ID: 36408631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose.
    Kühn T; Speer C; Morath C; Bartenschlager M; Kim H; Beimler J; Buylaert M; Nusshag C; Kälble F; Reineke M; Töllner M; Klein K; Blank A; Parthé S; Schnitzler P; Zeier M; Süsal C; Bartenschlager R; Tran TH; Schaier M; Benning L
    Transplantation; 2023 May; 107(5):1139-1150. PubMed ID: 36617671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need.
    Cheng Y-L; Chang S-S; Chao C-H; Chen P-T; Lin Y-L; Syu G-D; Lee N-Y; Chen P-L; Ko W-C; Ho T-S
    Microbiol Spectr; 2024 Jun; 12(6):e0000424. PubMed ID: 38747636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients.
    Kolb T; Fischer S; Müller L; Lübke N; Hillebrandt J; Andrée M; Schmitz M; Schmidt C; Küçükköylü S; Koster L; Kittel M; Weiland L; Dreyling KW; Hetzel G; Adams O; Schaal H; Ivens K; Rump LC; Timm J; Stegbauer J
    Kidney360; 2021 Sep; 2(9):1491-1498. PubMed ID: 35373105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients.
    Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N
    Front Immunol; 2022; 13():1050211. PubMed ID: 36532067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients.
    Körber N; Holzmann-Littig C; Wilkens G; Liao BH; Werz ML; Platen L; Cheng CC; Tellenbach M; Kappler V; Lehner V; Mijočević H; Christa C; Assfalg V; Heemann U; Schmaderer C; Protzer U; Braunisch MC; Bauer T; Renders L
    Front Immunol; 2023; 14():1172477. PubMed ID: 37063863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients.
    Kantauskaite M; Müller L; Kolb T; Fischer S; Hillebrandt J; Ivens K; Andree M; Luedde T; Orth HM; Adams O; Schaal H; Schmidt C; Königshausen E; Rump LC; Timm J; Stegbauer J
    Am J Transplant; 2022 Feb; 22(2):634-639. PubMed ID: 34551181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination.
    Al Jurdi A; Gassen RB; Borges TJ; Solhjou Z; Hullekes FE; Lape IT; Efe O; Alghamdi A; Patel P; Choi JY; Mohammed MT; Bohan B; Pattanayak V; Rosales I; Cravedi P; Kotton CN; Azzi JR; Riella LV
    Front Immunol; 2022; 13():838985. PubMed ID: 35281011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study.
    Yahav D; Rahamimov R; Mashraki T; Ben-Dor N; Steinmetz T; Agur T; Zingerman B; Herman-Edelstein M; Lichtenberg S; Ben-Zvi H; Bar-Haim E; Cohen H; Rotem S; Elia U; Margalit I; Zvi BR
    Transpl Int; 2022; 35():10204. PubMed ID: 35529596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination.
    Zhang L; Yang J; Deng M; Xu C; Lai C; Deng X; Wang Y; Zhou Q; Liu Y; Wan L; Li P; Fang J; Hou J; Lai X; Ma F; Li N; Li G; Kong W; Zhang W; Li J; Cao M; Feng L; Chen Z; Chen L; Ji T
    Sci Rep; 2023 May; 13(1):7263. PubMed ID: 37142713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients.
    Bertrand D; Hamzaoui M; Lemée V; Lamulle J; Hanoy M; Laurent C; Lebourg L; Etienne I; Lemoine M; Le Roy F; Nezam D; Plantier JC; Boyer O; Guerrot D; Candon S
    J Am Soc Nephrol; 2021 Sep; 32(9):2147-2152. PubMed ID: 34112706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS-CoV-2 mRNA vaccine.
    Borgogna C; Ferrante D; Rosso G; Guglielmetti G; Lo Cigno I; Raviola S; Caneparo V; Quaglia M; Cantaluppi V; Gariglio M
    J Med Virol; 2024 Jun; 96(6):e29710. PubMed ID: 38804187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic.
    Reischig T; Kacer M; Vlas T; Drenko P; Kielberger L; Machova J; Topolcan O; Kucera R; Kormunda S
    Am J Transplant; 2022 Mar; 22(3):801-812. PubMed ID: 34860470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine dose.
    Werbel WA; Karaba AH; Chiang TP; Massie AB; Brown DM; Watson N; Chahoud M; Thompson EA; Johnson AC; Avery RK; Cochran WV; Warren D; Liang T; Fribourg M; Huerta C; Samaha H; Klein SL; Bettinotti MP; Clarke WA; Sitaras I; Rouphael N; Cox AL; Bailey JR; Pekosz A; Tobian AAR; Durand CM; Bridges ND; Larsen CP; Heeger PS; Segev DL;
    Am J Transplant; 2023 Jun; 23(6):744-758. PubMed ID: 36966905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India.
    Jasuja S; Jha V; Sagar G; Bahl A; Verma S; Jasuja N; Kaur J
    Clin Kidney J; 2022 Jul; 15(7):1312-1321. PubMed ID: 35747093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients.
    Ohki Y; Kawabe M; Yamamoto I; Katsumata H; Nakada Y; Kobayashi A; Urabe F; Miki J; Yamada H; Kimura T; Matsuo N; Tanno Y; Horino T; Ohkido I; Yamamoto H; Yokoo T
    Front Microbiol; 2022; 13():922042. PubMed ID: 35756063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.